ARTICLE

FindCenter AddIcon

Opening Up the Future of Psychedelic Science

By Thomas Anderson and Rotem Petranker — 2018

There is a growing research literature suggesting psychedelics hold incredible promise for treating mental health ailments ranging from depression and anxiety to PTSD. But how do we know for sure?

Read on theconversation.com

FindCenter Post-Image

For the First Time, Scientists Have Imaged the Brain on LSD

The scientists hope their long-awaited study on LSD in humans will open the floodgates to further research into psychedelics.

Article
Victoria Turk
2016
FindCenter AddIcon
FindCenter Post-Image

DMT Alters Cortical Travelling Waves

These results support a recent model proposing that psychedelics reduce the ‘precision-weighting of priors’, thus altering the balance of top-down versus bottom-up information passing.

Article
Andrea Alamia, Christopher Timmermann, David J Nutt, Rufin VanRullen, Robin L Carhart-Harris
2020
FindCenter AddIcon
FindCenter Post-Image

The Trip Treatment

Research into psychedelics, shut down for decades, is now yielding exciting results.

Article
Michael Pollan
2015
FindCenter AddIcon
FindCenter Post-Image

DMT Models the Near-Death Experience

Near-death experiences (NDEs) are complex subjective experiences, which have been previously associated with the psychedelic experience and more specifically with the experience induced by the potent serotonergic, N,N-Dimethyltryptamine (DMT).

Article
Christopher Timmermann, Leor Roseman, Luke Williams, David Erritzoe, Charlotte Martial, Héléna Cassol, Steven Laureys, David Nutt and Robin Carhart-Harris
2018
FindCenter AddIcon
FindCenter Post-Image

Dr. Robin Carhart-Harris Is the First Scientist in Over 40 Years to Test LSD on Humans—And You're Next

The scientist talks to Laurence Phelan about fighting the establishment, battling preconceptions and breaking down egos.

Article
Laurence Phelan
2014
FindCenter AddIcon
FindCenter Post-Image

Scientists Gave Depressed Patients Psilocybin in a First for Psychedelic Therapy

In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.

Article
Victoria Turk
2016
FindCenter AddIcon
FindCenter Post-Image

We Can No Longer Ignore the Potential of Psychedelic Drugs to Treat Depression

At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.

Article
Robin Carhart-Harris
2020
FindCenter AddIcon
FindCenter Post-Image

Magic Mushrooms Expand the Mind by Dampening Brain Activity

A new brain-scan study helps explain how psilocybin works—and why it holds promise as a treatment for depression, addiction and post-traumatic stress.

Article
Maia Szalavitz
2012
FindCenter AddIcon
FindCenter Post-Image

Your Brain on Psilocybin

How magic mushrooms expand consciousness.

Article
Robin Carhart-Harris
2014
FindCenter AddIcon

EXPLORE TOPIC

Psychedelic Research